Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Hold Vessel Cleaning and Sterilization – V 2.0

Posted on By


Biosimilars: SOP for Hold Vessel Cleaning and Sterilization – V 2.0


Standard Operating Procedure for Hold Vessel Cleaning and Sterilization in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/193/2025
Supersedes SOP/BS/193/2022
Page No. Page 1 of 9
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a GMP-compliant procedure for cleaning and sterilizing stainless steel or single-use hold vessels used for biosimilar drug substance storage, ensuring microbial and chemical cleanliness prior to use.

2. Scope

This SOP applies to all portable and fixed hold vessels used in downstream processing and purified bulk storage areas within biosimilar manufacturing operations.

3. Responsibilities

  • Manufacturing Operator: Execute cleaning and sterilization procedures as per batch and equipment log.
  • Maintenance: Ensure integrity and calibration of steam sterilization or CIP/SIP systems.
  • QA: Review cleaning records and validate cleanliness status before batch use.

4. Accountability

The Head of Manufacturing and Head of QA are accountable for compliance with cleaning validation, sanitation schedules, and preventive maintenance of hold vessels.

5. Procedure

5.1 Pre-Cleaning Inspection

  1. Visually inspect vessel interiors for any residual product, stains, or foreign material.
  2. Ensure all vessel accessories (e.g., gaskets, valves, spray balls) are intact and in validated configuration.

5.2 Cleaning Process

  1. Rinse hold vessel with purified water (PW) to remove loose debris.
  2. Apply validated cleaning agent (e.g., alkaline detergent) using either manual scrubbing or automated CIP system.
  3. Rinse thoroughly with PW followed by WFI (Water for Injection) until rinse water is clear and pH neutral.
  4. Collect final rinse sample for TOC (Total Organic Carbon) and conductivity testing (Annexure-1).

5.3 Visual and Analytical Verification

  1. Post-cleaning, visually inspect vessel interior under adequate lighting for cleanliness.
  2. Record inspection result in Annexure-2 and attach cleaning checklist to equipment logbook.

5.4 Sterilization Process

  1. Connect vessel to validated SIP (Steam-In-Place) system or use autoclave (for small vessels).
  2. Achieve sterilization temperature (121°C) for defined hold time (e.g., 30 minutes).
  3. Monitor and document sterilization parameters (Annexure-3).

5.5 Storage and Status Labeling

  1. Once sterilized, apply “CLEANED & STERILE” label with date, time, and initials.
  2. Store vessel in designated clean area under covered condition to avoid contamination.

5.6 Hold Time Validation

  1. Do not use vessel beyond validated hold time post-sterilization (e.g., 72 hours).
  2. If hold time is exceeded, repeat the cleaning and sterilization cycle.

5.7 Deviation Handling

  1. In case of failed TOC, microbial load, or visible residue, document deviation and re-clean the vessel.
  2. Investigate root cause and log in Annexure-4.

6. Abbreviations

  • CIP: Clean-in-Place
  • SIP: Steam-in-Place
  • WFI: Water for Injection
  • TOC: Total Organic Carbon

7. Documents

  1. Final Rinse Sample Test Report – Annexure-1
  2. Visual Inspection Checklist – Annexure-2
  3. Sterilization Cycle Report – Annexure-3
  4. Cleaning Deviation Form – Annexure-4

8. References

  • ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
  • WHO GMP Annex 4 – HVAC and Cleanroom Classification
  • FDA Guidance on Cleaning Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Final Rinse Sample Test Report

Date Equipment ID TOC (ppb) Conductivity (µS/cm) Tested By
04/05/2025 HV-012 38 1.1 Neha Rao

Annexure-2: Visual Inspection Checklist

Date Equipment ID Interior Clean? Residue Present? Inspector
04/05/2025 HV-012 Yes No Ajay Verma

Annexure-3: Sterilization Cycle Report

Date Equipment ID Temp (°C) Hold Time (min) Operator
04/05/2025 HV-012 121.5 30 Sunita Reddy

Annexure-4: Cleaning Deviation Form

Date Deviation Description Root Cause Corrective Action QA Reviewer
03/05/2025 TOC > limit Inadequate rinse Repeat rinse with WFI Dr. Neha Rao

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added hold time validation and deviation reporting annexures GMP Enhancement
See also  Biosimilars: SOP for Cleaning Validation of Single-Use Systems - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Quality Assurance: SOP for Supplier Qualification Audits – V 2.0
Next Post: Outdated Site Master File Presented During Inspection: A GMP Readiness Concern

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version